Germany· DE-A57-65507a7a363d8154

Clindafanal

A clindamycin product containing clindamycin phosphate, registered in Germany by Dr. Pfleger Arzneimittel Gmbh. The same ATC class is registered in 14 of our 19 countries.

ATC G01AA10

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedClindafanalATCG01AA10REGISTER NO.DE-A57-65507a7a363d81…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Clindamycin is registered in 14 of 19 countries.

Countries holding a registration under ATC G01AA10 (clindamycin), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 9 of them publish a price we can compare per daily dose

Clindamycin · ATC G01AA10

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clindamycin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Clindamycin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • US United States$0.063 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Clindamycin Phosphate
Manufacturer
Dr. Pfleger Arzneimittel Gmbh
Country
Germany (DE)
ATC code
G01AA10
ATC class
Clindamycin
Defined daily dose
0.1 g, V
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for clindamycin.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Clindamycin · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • TubocurarineM03AA02moderate
  • SuxamethoniumM03AB01moderate
  • PancuroniumM03AC01moderate
  • VecuroniumM03AC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clindamycin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clindamycin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Clindac, Clindamycin 1a Pharma
  • Belgium · Clindamycin Noridem, Clindamycin Sandoz
  • Bulgaria · Clindamycin Kabi, Далацин C
  • Cyprus · Arfarel, Clindamycin Abr
  • Czechia · Clindamycin Hameln, Clindamycin Kabi
  • Denmark · Clindamycin Abcur, Clindamycin Alternova
  • Estonia · Clindamycin Mip, Dalacin
  • Spain · Clindamicina Aristo, Clindamicina Kalceks
  • Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
  • France · Clindamycine Kabi, Clindamycine Kalceks
  • United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
  • Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
  • Croatia · Aknet, Dalacin
  • Hungary · Clindamycin Anfarm, Clindamycin Hameln
  • Ireland · Clindamycin, Clindamycin Kalceks
  • Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
  • Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
  • Lithuania · Clindamycin Mip, Dalacin C
  • Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
  • Latvia · Clindamycin Kalceks, Clindamycin Mip
  • Malta · Clidacin Ba Free Amp, Clindamicina Accord
  • Netherlands · Clindamycin Teva, Clindamycine Added Pharma
  • Norway · Clindamycin Abcur, Clindamycin Kalceks
  • Poland · Clindacne, Clindalin
  • Portugal · Clincina, Clindamicina Generis
  • Romania · Clindamicină Hameln, Clindamycin Mip
  • Sweden · Clindamycin Abcur, Clindamycin Actavis
  • Slovenia · Dalacin, Klimicin
  • Slovakia · Clindamycin Hameln, Clindamycin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/588af88a-1f49-4238-a2a8-ec878e0fad4e
GET /v1/drugs/588af88a-1f49-4238-a2a8-ec878e0fad4e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Vaginal Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Clindamycin Phosphate",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about clindamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.